GLP-1 agonists for weight loss are now commonly used for adults, but might they also be an effective treatment for younger people? Katharine Lang reports Obesity in children and adolescents is a ...

Insanely beautiful and glossy people are telling me why I should or shouldn't take weight loss drugs. There's no denying that ...

Hundreds of Britons are being rushed to hospital with serious reactions to weight-loss drugs, with cases surging by 46 per ...

Hundreds of people have been hospitalised by the side effects of weight-loss drugs. There were 118 in November alone, ...

Novo Nordisk has won a Committee for Medicinal Products for Human Use (CHMP) endorsement for a higher-dose version of its diabetes drug liraglutide that can be used to treat obesity. The Danish ...

The study used the company's older GLP-1 agonist therapy Saxenda (liraglutide), which requires a daily injection, rather than its top-selling once-weekly obesity drug Wegovy (semaglutide), and ...

Novo Nordisk faces scrutiny over UK pharmacy sponsorships tied to weight-loss drugs, with critics citing conflicts of interest and regulatory breaches.

Figures from the Medicines and Healthcare products Regulatory Agency show that increasing numbers need medical treatment ...